Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC

INTRODUCTION: During treatment with immune checkpoint inhibitors, immune-related adverse events sometimes occur, and their management is a critical concern associated with such treatment. Encephalitis and meningitis are some of the critical immune-related adverse events. Atezolizumab is an immune ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyozawa, Ryo, Haratake, Naoki, Toyokawa, Gouji, Matsubara, Taichi, Takamori, Shinkichi, Miura, Naoko, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro, Seto, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474468/
https://www.ncbi.nlm.nih.gov/pubmed/34589914
http://dx.doi.org/10.1016/j.jtocrr.2020.100012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474468/
https://www.ncbi.nlm.nih.gov/pubmed/34589914
http://dx.doi.org/10.1016/j.jtocrr.2020.100012

Ejemplares similares